Related Experiment Video

Updated: Aug 13, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Immunobiology of oligodendrocytes in multiple sclerosis

Francesca Ruffini1, Andrew Chojnacki, Samuel Weiss

  • 1Neuroscience-Neuroimmunology Unit, DIBIT-San Raffaele Hospital, Milan, Italy.

Advances in Neurology
|January 13, 2006
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning
11:11

Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning

Published on: February 17, 2016

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Related Experiment Videos

Last Updated: Aug 13, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning
11:11

Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning

Published on: February 17, 2016

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Articles linked to this work by shared authors, journal, and citation graph.

Glioblastoma stem cell growth requires DOT1L-MED23 control of enhancer accessibility.

Cell reports·2026

Age and Maturation Stage Linked Consequences of Fibrinogen on Human Oligodendroglia.

Journal of neuroscience research·2026

Enhanced myelination potential of human mature oligodendrocytes by TNF and IFNG combination.

Journal of neuroinflammation·2026

IGF2 supports glioblastoma growth and immune evasion through a combination of tumor cell-intrinsic and -extrinsic mechanisms.

Neuro-oncology advances·2026

In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis.

Science translational medicine·2026

Interleukin-9 Regulates NF-kB-Mediated Activation of Astrocytes in Multiple Sclerosis Brain.

Neurology(R) neuroimmunology & neuroinflammation·2026

Behavior therapy: other interventions for tic disorders.

Advances in neurology·2006

Treatment of aggression in Tourette syndrome.

Advances in neurology·2006

Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders.

Advances in neurology·2006

Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.

Advances in neurology·2006

Preclinical models relevant to Tourette syndrome.

Advances in neurology·2006

Comparable long-term outcomes with biosimilar and originator adalimumab in juvenile idiopathic arthritis: a multicenter cohort study.

Expert opinion on biological therapy·2026

Serum levels of guanidinylated YB-1 indicate active lupus nephritis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

Revisiting CD8+ T Cells in Allergy: The Emerging Role of Tc2 Cells.

Scandinavian journal of immunology·2026

Giardia duodenalis Infection and Pachymeningitis in a Patient With Agammaglobulinemia.

Clinical pediatrics·2026

Use of sutimlimab to manage anemia in a patient with high-grade B-cell lymphoma and complement binding anti-AnWj autoantibody.

Transfusion·2026

Giant paratesticular immunoglobulin G4-related disease mimicking malignancy: A case report.

Urology case reports·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us